Fig. 2From: Multidomain trials to prevent dementia: addressing methodological challengesRepresentation of how “risk reduction scores” can be included in the analyses and interpretation of results when designing “standardly tailored’” trials targeting multiple risk factors, as we have designed for the SYNERGIC-2 Trial (CT.gov #3948). MCI, mild cognitive impairmentBack to article page